Thomas Jefferson University

Jefferson Digital Commons
Department of Pediatrics Faculty Papers

Department of Pediatrics

11-1-1997

Predicting red blood cell transfusions in very low birth weight
infants based on clinical risk factors.
David A. Paul
Medical Center of Delaware; Thomas Jefferson University

Stephen A. Pearlman
Medical Center of Delaware; Thomas Jefferson University

Kathleen H. Leef
Medical Center of Delaware

John L. Stefano
Medical Center of Delaware; Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/pedsfp
Part of the Bioethics and Medical Ethics Commons, and the Pediatrics Commons

Let us know how access to this document benefits you
Recommended Citation
Paul, David A.; Pearlman, Stephen A.; Leef, Kathleen H.; and Stefano, John L., "Predicting red
blood cell transfusions in very low birth weight infants based on clinical risk factors." (1997).
Department of Pediatrics Faculty Papers. Paper 47.
https://jdc.jefferson.edu/pedsfp/47
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Pediatrics Faculty Papers by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

SCIENTIFIC ARTICLE

Predicting Red Blood Cell Transfusions in Very Low Birth
Weight Infants Based on Clinical Risk Factors
David A. Paul, M.D. — Stephen A. Pearlman, M.D. — Kathleen H. Leef, R.N.
John L. Stefano, M.D.

ABSTRACT
Objective: to describe the clinical factors most predictive of red blood cell transfusion in very low birth weight
(VLBW) infants.
Study design: retrospective review of VLBW infants cared for at a single level III NICU during a two year
period, n=199.
Results: overall transfusion requirement was 4.6 ± 6.2 transfusions/infant/hospital course. Length of hospital
stay, days of mechanical ventilation, requirement for dopamine support, birth weight, initial hematocrit,
periventricular leukomalacia and necrotizing enterocolitis all independently correlated with number of
transfusions and donors. Bronchopulmonary dysplasia and patent ductus arteriosus were associated with
donor but not transfusion number.
Conclusions: our data characterize the population of VLBW infants with the greatest blood transfusion and
donor requirement. Further investigation is needed to target this population for interventions to reduce blood
exposure.

Anemia of prematurity with the subsequent need
to transfuse red blood cells (RBC) is a common
problem in preterm infants. The most promising
intervention to reduce the number of RBC transfusions in preterm infants has been the use of
recombinant human erythropoietin which has
been shown to safely stimulate erythropoiesis
and decrease the requireent for transfusions in
Other interventions
selected preterm infants.
such as transfusion of placental blood, 4 and
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changing the preservative of red blood cells to
allow transfusion of older blood 5 have also
been suggested in order to decrease postnatal
donor exposure but have not been extensively
investigated in studies involving large numbers
To date, the sub-population of
of infants.
preterm infants who would most likely benefit
from these new therapies has been poorly defined. The purpose of this study was to: 1)
determine which preterm infants require the most
transfusions of RBC and have the greatest donor
exposure and 2) establish the population of
infants that would potentially derive the greatest
benefit from interventions to limit exposure to
blood products. In order to meet these goals we
retrospectively created multivariate linear regression models to determine the clinical variables determining both RBC transfusion and
donor number.
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METHODS
The study consisted of a retrospective review of
infants admitted to the intensive care nursery at
the Medical Center of Delaware from July 1,
1993 to July 1, 1995. The Medical Center of
Delaware is a level III neonatal intensive care
unit caring for both inborn and outborn infants.
All data were obtained from a review of a
computerized database and confirmed by chart
review. Infants were included in the analysis if
they had a birth weight less than 1500 grams and
were offered intensive care. In order to establish
the relationship of blood transfusion with intraventricular hemorrhage and bronchopulmonary
dysplasia, infants were only included if they met
the above criteria, had a minimum of one cranial
sonogram, and survived to 28 days of life,
n=199. Infants not analyzed included: 22 infants who were admitted and transfused but died
prior to 28 days of life, and two infants (1380
grams and 1490 grams) not transfused who did
not receive a cranial sonogram at the discretion
of the attending neonatologist.
For the purpose of this study, a blood transfusion
was considered the administration of packed red
blood cells as ordered by the attending neonatologist. All transfused blood is negative for
cytomegalovirus, irradiated, less than seven days
old and stored in citrate-phosphate-dextroseadenine preservative. Blood from a single donor, which was ordered to be split into multiple
smaller aliquots, and transfused within 24 hours,
was considered a single transfusion. If an infant
received a second transfusion > 24 hours following an original transfusion, but before the
seven day expiration period of the blood, the
transfusion was considered a second transfusion
but a single donor exposure. Therefore infants
often receive multiple transfusions from a single
donor. All transfusions ordered after the seven
day expiration period of the original unit were
from a different donor.
The following general criteria are adhered to in
our nursery: most transfusions ranged from ten
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to 15 cc/kg per transfusion. During the acute
phase of respiratory distress syndrome, infants
are transfused to keep the hematocrit greater
than 35-40 percent. Anemic preterm infants
who are more stable and receiving enteral feeds
and no supplemental oxygen were transfused
only if they are felt to be symptomatic. These
symptoms included: tachycardia, tachypnea, poor
weight gain while receiving adequate calories,
and frequent apnea unresponsive to other therapies.
The independent variables studied are listed
(Table 1). For the purpose of this study gestational age was defined by the best obstetrical
estimate or if not available by Ballard exam. 6
Patients were given the diagnosis of bacterial
sepsis if they had a positive blood culture and.the
diagnosis of patent ductus arteriosus if confirmed by echocardiography. Bronchopulmonary dysplasia was defined as a requirement for
supplemental oxygen at 28 days of life. 7 Prolonged rupture of membranes was defined as
being greater than 24 hours in duration. Premature rupture of membranes was defined as rupture before 37 weeks of gestation.
Multivariate linear regression models were created in order to determine which clinical factors
were most predictive of the number of transfusions and the number of donors. Number of red
blood cell transfusions and number of donors
served as the dependent variables. Independent
variables entered in the models were determined
by performing a preliminary univariate analysis
as well as multiple linear regressions. Forward
stepwise analysis was performed in order to
determine variables independently associated
with transfusion and donor number. Validity of
the models was confirmed by plotting residuals
versus expected normal values and residuals
versus predicted values. All data are expressed
as mean ± standard deviation, unless otherwise
noted. All statistical calculations were performed
on commercially available software (Statistica,
Tulsa, OK).
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Table 1. Independent variables studied in multivariate
models. Dependent variables, transfusion number and
donor number.
INDEPENDENT VARIABLES STUDIED
Gestational Age
Birth Weight
Intrauterine Growth Restriction
Length of Hospital Stay
Gender
Mechanical Ventilation
High Frequency Ventilation
Days of Mechanical Ventilation
Continuous Positive Airway Pressure
Days of Continuous Positive Airway Pressure
Days of Supplemental Oxygen
Prenatal Steroids
Exogenous Surfactant
Apnea of Prematurity
Caffeine

RESULTS
The overall requirement for transfusions of RBC
was 4.6 ± 6.2 per infant/hospital course (range
0-40). Thirty-five percent of the study population
did not require any RBC transfusions throughout
their hospital course, while five percent required
only a single transfusion, 13 percent required
two to three RBC transfusions, 12 percent required four to five RBC transfusions and the
remaining 35 percent required six or more transfusions. The mean number of donors was 2.6 ±
3.1 per infant / hospital course (range 0 -17).
Thirty-five percent had no donor exposures, while
ten percent had a single exposure, 20 percent
had two to three exposures, 18 percent had four
to five exposures, and the remaining 17 percent
had six or more RBC donors. None of the infants
in the study received recombinant erythropoietin. The demographic makeup of the study
population is listed in Table 2.

Dopamine
Dobutamine
Initial Hematocrit
Patent Ductus Arteriosus
Bacterial Sepsis
Intraventricular Hemorrhage
Severe Intraventricular Hemorrhage, grade III-IV
Periventricular Leukomalacia
Necrotizing Enterocolitis
Bronchopulmonary Dysplasia
Seizures

Variables independently correlating with number
of RBC transfusions included: length of hospital
stay (p<.00001), number of days of mechanical
ventilation (p < .0001), requirement for dopamine support (p< .00001), diagnoses of
periventricular leukomalacia (p=.00004) and
necrotizing enterocolitis (p= .002), birth weight
(p=.002), and initial hematocrit (p=.04). The
overall model had an r=0.9 (p<.001). None of
the other variables studied (Table 1) correlated
with number of transfusions.

Pneumothorax
Mortality
Preeclampsia
Premature Labor
Maternal Substance Abuse
Multiple Gestation
Prolonged Rupture of Membranes
Premature Rupture of Membranes
Maternal Urinary Tract Infection
Chorioamnionitis
Oligohydramnios
Maternal Age
Number of Platelet Transfusions

Variables associated with number of donors
included: length of hospital stay (p<.00001),
number of days of mechanical ventilation (p <
.00001), requirement for dopamine support (p<
.00001), diagnoses of bronchopulmonary dysplasia (p=.0004) and periventricular
leukomalacia (p=.01), birth weight (p=.03),
initial hematocrit (p=.03) and diagnoses of necrotizing enterocolitis (p= .03) and patent ductus arteriosus (p=.04). The overall model had
an r=0.91 (p<.00001). None of the other variables studied (Table 1) were associated with
number of donors.

Prenatal magnesium sulfate
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Because most of the variables correlating with
number of transfusions and number of donors in
the above models are not known until later in an
infant's hospital course, an attempt was made to
create a model using variables available at the
time of birth. Using only birth weight and initial
hematocrit as the independent variables and
transfusion number as the dependent variable
had an r =.71 (p<.001). Using donor number
as the dependent variable with the same independent variables had an r=.69 (p<.001).

DISCUSSION
The etiology of the anemia of prematurity is
multifactorial. The pathophysiology results from
an attenuated erythropoietin response to tissue
hypoxia, 8 iatrogenic blood loss, 9,10 and shortened life span of RBC containing fetal hemoglobin. 9 Although the risk of HIV infection from
random donor blood is one in 450,000 to one in
600,000 in the United States, 11 transfusion of
blood products is associated with significant
parental anxiety. Other risks from exposure to
blood products include: hepatitis B and C, as
well as volume overload, electrolyte disturbances,
iron overload and graft versus host disease.12
These risks highlight the importance of developing methods to decrease transfusion and donor
number in this population. Our data demonstrate that length of hospital stay, days of mechanical ventilation and need for dopamine
support are the variables most predictive of
number of transfusions and donors. Birth weight,
initial hematocrit, periventricular leukomalacia
and necrotizing enterocolitis are also independent predictors of transfusion and donor number. Diagnosis of patent ductus arteriosus and
bronchopulmonary dysplasia are related to donor number but not transfusion number.

To our knowledge this report is the first to
correlate length of hospital stay with transfusion
and donor number. We speculate that infants
with prolonged length of stay had increased
phlebotomy losses. Obladen et al have previ-
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Table 2. Demographic make-up of the study population.
DEMOGRAPHIC DATA (n=199)

Birth Weight (grams)

1089 ± 279*

Gestational Age (weeks)

28.5 ± 2.9*

Apgar Score -1 minute

5.0**

Apgar Score-5 minutes

8.0**

Male Gender

107 (54%)

C-section

107 (54%)

CPAP

151 (76%)

Mechanical Ventilation

148 (74%)

Patent Ductus Arteriosus

36 (18%)

Intraventricular Hemorrhage (grade I-IV)

27 (14%)

Bronchopulmonary Dysplasia

92 (46%)

Sepsis

34 (17%)

Necrotizing Enterocolitis

13 (7%)

Dopamine

41 (21%)

Exogenous Surfactant

141 (71%)

Initial Hematocrit (%)

45.1 ±7.5*

Length of Stay (days)

63.8 ± 27.6*

* Mean ± sd
** Median

ously demonstrated that infants of lower birth
weight and infants who require respiratory sup10
port have increased blood sampling. Phlebotomy data was not included in this investigation because it was not uniformly available in our
population. Number of transfusions and donors
may also be related to length of stay because of
a prolonged opportunity to transfuse infants, as
the hematocrit of infants discharged to home is
generally unknown to the attending physician.
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Further investigation is needed to study the strong
association of length of stay with transfusion and
donor number.
In addition to length of stay, prolonged mechanical ventilation was associated with transfusion and donor number in our population. Again,
this finding may be secondary to higher phlebotomy requirements in preterm infants with a
need for supplemental oxygen. 10 However, the
exact hemoglobin and level of respiratory support at which oxygen delivery becomes compromised is unknown and can only be estimated
based on unreliable clinical parameters. Our
finding that periventricular leukomalacia, necrotizing enterocolitis, and use of dopamine are
associated with transfusion and donor number
reflect the requirement for transfusion in conditions with impaired tissue oxygenation. Our data
emphasize the need to target infants with these
conditions for reducing donor exposure. Investigation of the relationship between oxygen supply and demand in infants with hypotension,
respiratory compromise, intestinal and cerebral
ischemia would aid in establishing strict guidelines for transfusing infants with these conditions.
An important part of the pathophysiology of the
anemia of prematurity involves diminished response of premature infants in producing erythropoietin to a hypoxic stimulus. 8 Because of this
attenuated ability to produce endogenous erythropoietin, treatment with recombinant human
erythropoietin has been employed as a therapy
for anemia of prematurity. " However, the
population of preterm infants who would derive
the greatest benefit from this therapy has yet to
be elucidated. In our population of VLBW infants, birth weight and initial hematocrit were
predictive of transfusion and donor number.
Gestational age was not predictive after multivariate analysis. This relationship is due to close
correlation of the two variables, with birth weight
superseding gestational age in the multivariate
models. Brown et al have previously demonstrated gestational age less than 30 weeks to be
most predictive of the need for greater than two
14
transfusions.
In contrast to this data which
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indicate that infants of the youngest gestational
age receive the highest number of transfusions,
previous studies have shown that recombinant
human erythropoietin is most effective when
administered to larger infants. 2,3 Only one
double blind placebo controlled study of recombinant erythropoietin has include infants less
1
than 750 grams. Furthermore, Maier et al
demonstrated that low birth weight and gestational age were most predictive of transfusion in
a population of infants receiving erythropoietin: Although our data indicate that recombinant human erythropoietin would have the greatest impact if offered to the smallest infants,
administration of erythropoietin to extremely low
birth weight infants (<1000g) may be limited by
the need to supplement enteral iron and the
need for frequent intramuscular injections. 16
Additional study is needed to determine how to
safely and effectively administer this drug to
infants of the lowest birth weight.
Anemia of prematurity has been .Dreviously classified into early and late anemia. Early anemia
of prematurity is associated with high phlebotomy
losses. This association was emphasized in the
erythropoietin trial of Shannon et al, in which
infants received a mean of 3.5 transfusions prior
to enrollment. 1 In our population, bronchopulmonary dysplasia and patent ductus arteriosus
were predictive of donor number but not transfusion number. The need for surgical ligation of a
patent ductus has previously been shown to be
associated with increased blood transfusion. 14
We speculate that these factors were associated
with donor number and not transfusion number
in our population, because infants with these
conditions continued to receive transfusions later
in their hospital course at which time they are
likely to be exposed to a new donor with each
transfusion.
Many of the variables associated with donor and
transfusion number in our investigation are not
known to the clinician at the time of birth; for
example, the diagnosis of bronchopulmonary
dysplasia or the length of hospital stay. Although
our data indicate that these factors are important

559

Scientific Article

in contributing to the need for transfusion, it may
be difficult to develop a treatment strategy using
these variables. A more useful model may be
one using variables known at birth, allowing
early intervention, since the majority of transfusions occur during the early part of an infant's
hospital stay. 17 The models created using only
birth weight and initial hematocrit correlated
well with transfusion and donor number. Therefore, these clinical variables, while not accounting for all the clinical conditions and variability
associated with RBC transfusion, may be used
early in an infant's hospital course to predict
transfusion number, initiate interventional strategies, and counsel parents.
In conclusion, our data are the first to demonstrate an association between length of hospital
stay, transfusion and donor number in a population of VLBW infants. Defining the population of
infants at greatest risk provides a target for
intervention. Along with erythropoietin, strict
transfusion criteria, strategies to decrease phlebotomy losses, and autologous transfusion have
all been proposed to decrease donor exposure
in infants. Our data help to provide the ground
work to identify a population of infants who
would derive the greatest benefit from such
interventions. Further investigation is needed in
order to effectively apply these interventions to a
target population.
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